Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of remimazolam vs propofol for pediatric general anesthesia
ChiCTR2600128011Phase 2Completed
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of remimazolam (4 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Success rate of anesthesia. Started Jul 2026; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2600128011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128011.